Drug Type Small molecule drug |
Synonyms 4-(Benzyloxy)phenol, 4-(Benzyloxyl)phenol, 4-(Phenylmethoxy)phenol + [11] |
Target |
Action inhibitors |
Mechanism TYR inhibitors(Tyrosinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date United States (10 Nov 1952), |
Regulation- |
Molecular FormulaC13H12O2 |
InChIKeyVYQNWZOUAUKGHI-UHFFFAOYSA-N |
CAS Registry103-16-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D05072 | Monobenzone |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Vitiligo | United States | 10 Nov 1952 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma, Cutaneous Malignant | Phase 2 | Netherlands | 01 Mar 2011 |